1-2 of 2
Dominick Lamonica, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bendamustine Plus Rituximab (BR) in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma of a Phase 2 Study: Multivariate Analysis and Updated Final Results By Subgroup

Myron S. Czuczman, MD, Andre Goy, MD, Dominick Lamonica, MD, Daniel A. Graf, MD MPH, Mihaela C. Munteanu, MS, Richard H. van der Jagt, MD FRCP(C)
Journal: Blood
Blood (2014) 124 (21): 1757.
https://doi.org/10.1182/blood.V124.21.1757.1757
Published: 2014
Journal Articles

Open-Label Bendamustine Combined with Rituximab for Treatment of Relapsed/Refractory Mantle-Cell Lymphoma: Efficacy and Safety Findings

Myron S. Czuczman, MD, Dominick Lamonica, MD, Shari K. Gaylor, Leonard Bush, BHS, Penny Nadolny, Dave Colborn
Journal: Blood
Blood (2012) 120 (21): 3662.
https://doi.org/10.1182/blood.V120.21.3662.3662
Published: 2012